跳至主要内容
临床试验/NL-OMON28883
NL-OMON28883已完成不适用

Effects of omeprazole on the pharmacokinetics of irinotecan in cancer patients: An open-label crossover study.

Erasmus MC - Afdeling Interne Oncologie0 个研究点目标入组 14 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
14

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Histological or cytological confirmed diagnosis of any form of (irresectable and/or metastatic) cancer, which is thought to be sensitive to irinotecan-treatment;
  • 2. Age >= 18 years;

排除标准

  • 1. Pregnant or lactating patients; patients with reproductive potential must use a reliable method of contraception (excluding oral contraceptives), if required;
  • 2. Serious illness or medical unstable condition requiring treatment, symptomatic CNS-metastases or history of psychiatric disorder that would prohibit the understanding and giving of informed consent;

研究者

发起方
Erasmus MC - Afdeling Interne Oncologie

相似试验